Latest Breaking News On - அமெரிக்கன் தூங்கு மூச்சுத்திணறல் சங்கம் - Page 1 : vimarsana.com

Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product ACCESSWIRE VANCOUVER, BC / ACCESSWIRE / May 10, 2021 / NeutriSci International Inc. ( NeutriSci or the Company ) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce the Phase 1 R&D completion of a newly developed Cannabinol (CBN) product for the US marketplace. In conjunction with its contract manufacturing partner Pacwest, the completion of Phase 1 used NeutriSci s IP, technologies, and ingredients to create a finished CBN tablet product. CBN is known for is its sleepiness effect. When taken, it is known to cause drowsiness. Sleep problems are widespread in modern society. According to the Center for Disease Control, one in three adults do not get enough sleep. Sleep-deprived individuals are more likely to suffer from the most damaging health problems of the modern world, including co

United statesBritish columbiaGlen rehmanAmerican sleep apnea associationDrug administrationRegulation services providerVenture exchangeNeutrisci international incNeutrisci internationalDisease controlChain drugMass marketஒன்றுபட்டது மாநிலங்களில்பிரிட்டிஷ் கொலம்பியாக்ளென் ரெஹ்மான்அமெரிக்கன் தூங்கு மூச்சுத்திணறல் சங்கம்